Table 2.

The effects of combination treatment.

Combination Treatment	Effects
IRE ​+ ​Anti-PD-1	- Enhanced tumor-specific CD8+ T cell response
	- Increased recognition and presentation of tumor antigens by antigen-presenting cells
	- Improved postoperative anti-tumor immune response
	- Inhibition of tumor recurrence and metastasis
IRE ​+ ​Anti-OX40	- Enhanced killing effect of T cells on tumors
	- Increased Ox40 receptor expression
	- Strengthened postoperative anti-tumor immune response
	- Inhibition of tumor recurrence and metastasis
IRE ​+ ​Anti-CTLA-4	- Increased tumor-specific CD8+ T cell response
	- Presence of tumor-related memory-like T cells in tumor microenvironment
	- Prevention of tumor progression and adverse events
	- Enhanced tumor immune response